Brazil through the ministry of heath has suspended clinical trials of Sinovac COVID-19 from China from what they said was due to adverse reactions.
The medical team from Sao Paulo spoke after the news saying they were shocked by the decision and that they will hold a press conference for clarity purposes.
- Pfizer, BioNTech reveal 90% effective COVID-19 vaccine
- Trump fires Secretary of Defense Mark Esper
- Kenya records 19 new COVID-19 deaths, tally now 1,130
Speaking on Monday, Dimas Covas the head of Butantan said that the decision was a result of a death reported but he clarified that the death was not connected to the vaccine.
Covas continued by confirming that they have about 10,000 volunteers and that death can occur but it has nothing to do with the vaccine thus no need to suspend the trials.
Other companies conducting the trials are still on course in many other countries including Turkey and Indonesia.
The news comes hours after a 90% effective vaccine was announced by Pfizer and German based BioNTech giving hope to humanity which has been under threat.
Investors were pleased with the news as energy and travel shares went up across the world.